EP2760853A4 - Nouveaux sels de l'alogliptine - Google Patents

Nouveaux sels de l'alogliptine

Info

Publication number
EP2760853A4
EP2760853A4 EP12836162.3A EP12836162A EP2760853A4 EP 2760853 A4 EP2760853 A4 EP 2760853A4 EP 12836162 A EP12836162 A EP 12836162A EP 2760853 A4 EP2760853 A4 EP 2760853A4
Authority
EP
European Patent Office
Prior art keywords
alogliptin
novel salts
salts
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12836162.3A
Other languages
German (de)
English (en)
Other versions
EP2760853A1 (fr
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Dasari Muralidhara
Maradolla Mohanbabu
Krishna Bandi Vamsi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Research Foundation
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of EP2760853A1 publication Critical patent/EP2760853A1/fr
Publication of EP2760853A4 publication Critical patent/EP2760853A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP12836162.3A 2011-09-26 2012-09-12 Nouveaux sels de l'alogliptine Withdrawn EP2760853A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3317CH2011 2011-09-26
PCT/IN2012/000611 WO2013046229A1 (fr) 2011-09-26 2012-09-12 Nouveaux sels de l'alogliptine

Publications (2)

Publication Number Publication Date
EP2760853A1 EP2760853A1 (fr) 2014-08-06
EP2760853A4 true EP2760853A4 (fr) 2015-10-28

Family

ID=47994371

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12836162.3A Withdrawn EP2760853A4 (fr) 2011-09-26 2012-09-12 Nouveaux sels de l'alogliptine

Country Status (2)

Country Link
EP (1) EP2760853A4 (fr)
WO (1) WO2013046229A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3049402B1 (fr) 2013-05-24 2019-02-27 Glenmark Pharmaceuticals Limited Procédé de préparation d'alogliptine
CN104725350A (zh) * 2013-12-23 2015-06-24 湖北华世通生物医药科技有限公司 阿格列汀盐酸盐的多晶b型晶体、其制备方法及生产用途
CN103923063B (zh) * 2014-04-11 2016-05-11 浙江永宁药业股份有限公司 一种苯甲酸阿格列汀的晶型及其制备方法
EP3292112B1 (fr) 2015-05-04 2019-08-14 Indoco Remedies Limited Procédé pour la préparation d' alogliptine
WO2017107945A1 (fr) * 2015-12-24 2017-06-29 山东轩竹医药科技有限公司 Forme cristalline de benzoate d'inhibiteur de dipeptidyl peptidase-iv
WO2017211293A1 (fr) * 2016-06-08 2017-12-14 山东轩竹医药科技有限公司 Forme cristalline du succinate servant d'inhibiteur de la dipeptidyl peptidase-4
CN105929084B (zh) * 2016-07-18 2018-11-23 江苏德源药业股份有限公司 高效液相色谱拆分苯甲酸阿格列汀及其对映异构体的方法
CN106749177A (zh) * 2016-12-30 2017-05-31 湖南千金湘江药业股份有限公司 一种苯甲酸阿格列汀的精制方法
CN113880900B (zh) * 2020-10-30 2023-07-07 杭州拉林智能科技有限公司 黄酮苷-有机胺类dpp-4抑制剂复盐化合物及其制备方法和应用
CN113698384B (zh) * 2021-10-26 2022-01-18 上海维京生物医药科技有限公司 阿格列汀没食子酸盐及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095381A1 (fr) * 2004-03-15 2005-10-13 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyle peptidase
WO2007033266A2 (fr) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Administration d'inhibiteurs de dipeptidyl peptidase
WO2007035629A2 (fr) * 2005-09-16 2007-03-29 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidylpeptidase
WO2010109468A1 (fr) * 2009-03-26 2010-09-30 Mapi Pharma Hk Limited Procédé de préparation d'alogliptine
WO2011141903A1 (fr) * 2010-05-12 2011-11-17 Mapi Pharma Holdings (Cyprus) Limited Polymorphes du benzoate d'alogliptine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661878A1 (fr) * 2004-11-26 2006-05-31 Dipharma S.p.A. Formes polymorphes d'Adapalene
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2009146097A1 (fr) * 2008-04-02 2009-12-03 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques de raloxifène

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095381A1 (fr) * 2004-03-15 2005-10-13 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyle peptidase
WO2007033266A2 (fr) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Administration d'inhibiteurs de dipeptidyl peptidase
WO2007035629A2 (fr) * 2005-09-16 2007-03-29 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidylpeptidase
WO2010109468A1 (fr) * 2009-03-26 2010-09-30 Mapi Pharma Hk Limited Procédé de préparation d'alogliptine
WO2011141903A1 (fr) * 2010-05-12 2011-11-17 Mapi Pharma Holdings (Cyprus) Limited Polymorphes du benzoate d'alogliptine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2013046229A1 *

Also Published As

Publication number Publication date
WO2013046229A1 (fr) 2013-04-04
EP2760853A1 (fr) 2014-08-06

Similar Documents

Publication Publication Date Title
HK1244183A1 (zh) Ivacaftor的氘化衍生物
HUE047354T2 (hu) Ivacaftor deuterizált származékai
IL229830B (en) Novel compinds as modulatord of gpr-119
EP2712362A4 (fr) Fabrication de lacto-n-tétraose
EP2723384A4 (fr) Traitement de protéinopathies
EP2673286A4 (fr) Composés thérapeutiques
EP2742051A4 (fr) Forme amorphe de dolutegravir
IL232599A (en) Hydrobromide salt of peridofidine
EP2717855A4 (fr) Procédés de traitement
EP2760853A4 (fr) Nouveaux sels de l'alogliptine
IL230976A (en) Crystalline forms of Czebitaxel
GB201304499D0 (en) Carcainium Salts
HK1195770A1 (en) Amorphous solid salts of cobicistat (gs-9350) (cobicistat)(gs-9350)
HK1203355A1 (en) Uses of 4-desferrithiocin analogs 4-
EP2785766A4 (fr) Sels d'hydroxypolyamine
EP2601178A4 (fr) Sels de la lapatinib
EP2684869A4 (fr) Préparation de 3-mercaptopropionates
EP2680843A4 (fr) Dérivés de composés amino-hétéroaryles substitués par des pyrazoles
IL230977A (en) A crystalline form of relapaldib
EP2782902A4 (fr) Dérivés d'acide phénoxyisobutyrique
PL395425A1 (pl) Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu
EP2702991A4 (fr) Composition d'entacopone
GB201102913D0 (en) Novel therapeutic
GB201106819D0 (en) Novel salts
IL231452A (en) An amorphous form of a dolotgrave

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140402

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 401/04 20060101AFI20150310BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150924

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 401/04 20060101AFI20150918BHEP

17Q First examination report despatched

Effective date: 20160916

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170923